FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Titles 4426. Misbranding of suprarenal concentrate capsules and yellow bone marrow concentrate. U. S. v. 213 Bottles, etc. ✖Remove constraint Titles: 4426. Misbranding of suprarenal concentrate capsules and yellow bone marrow concentrate. U. S. v. 213 Bottles, etc. Defendants Armour Laboratories ✖Remove constraint Defendants: Armour Laboratories

Refine by:

  • 4426. Misbranding of suprarenal concentrate capsules and yellow bone marrow concentrate. U. S. v. 213 Bottles, etc.1